Targeting Cancer Metabolism to Improve Outcomes with Immune Checkpoint Inhibitors
Immune checkpoint inhibitors have revolutionized the treatment paradigm of several cancers. However, not all patients respond to treatment. Tumor cells reprogram metabolic pathways to facilitate growth and proliferation. This shift in metabolic pathways creates fierce competition with immune cells f...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Innovative Healthcare Institute
2023-05-01
|
Series: | Journal of Immunotherapy and Precision Oncology |
Subjects: | |
Online Access: | https://jipo.org/doi/pdf/10.36401/JIPO-22-27 |